Nomura Holdings
PRAX icon

Nomura Holdings’s Praxis Precision Medicines PRAX Stock Holding History

Nomura Holdings’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.87M Hold
12,000
– – 0.01% 719
2025
Q4 		$3.54M Buy
+12,000
New +$2.23M ﹤0.01% 899

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Nomura Holdings's PRAX Position: Q1 2025 in Review

Nomura Holdings sold out of Praxis Precision Medicines (PRAX) in Q1 2025, closing a stake of 4,102 shares — an estimated $256K sold.

Nomura Holdings first reported a position in PRAX in Q4 2024 and held it in 1 quarter. The position peaked at $316K in Q4 2024. 150 funds tracked by Wall St. Rank hold PRAX as of Q1 2025.

  • Nomura Holdings reported no remaining Praxis Precision Medicines position as of Q1 2025 after selling out during the quarter.
  • Nomura Holdings sold 4,102 Praxis Precision Medicines shares in Q1 2025, an estimated $256K.
  • Nomura Holdings first reported a position in Praxis Precision Medicines in Q4 2024 and held it in 1 quarter.
  • Nomura Holdings's Praxis Precision Medicines position peaked at $316K in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2025.

Based on Nomura Holdings's 13F filing for Q1 2025, filed 15 May 2025.